November 12, 2019
VIA EDGAR TRANSMISSION
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Ms. Irene Paik
| Re: | ShockWave Medical, Inc. |
Registration Statement on FormS-1 |
Registration No. 333-234640 |
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on FormS-1 (File No. 333-234640) (the “Registration Statement”) of ShockWave Medical, Inc. (the “Company”). We respectfully request that the Registration Statement become effective as of 4:00 pm, Washington, D.C. time, on November 14, 2019, or as soon as practicable thereafter. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Davis Polk & Wardwell LLP, by calling Alan F. Denenberg at (650)752-2004.
Very truly yours,
SHOCKWAVE MEDICAL, INC. | ||
| By: | /s/ Douglas Godshall | |
Name: Douglas Godshall Title: President & Chief Executive Officer | ||
[Signature Page to Acceleration Request]
